North America Pharmaceuticals & Healthcare Views

Pages

FDA Approves Velphoro

On November 27, the FDA approved Velphoro (PA21; sucroferric oxyhydroxide) for the treatment of hyperphosphataemia in chronic kidney disease patients on dialysis. The product, owned by Vifor...

Read article ›
AMCP Launches Biosimilars Task Force

The Academy of Managed Care Pharmacy (AMCP)'s decision to establish a Biosimilars Task Force is an interesting development; it indicates that the wider healthcare business in the US is beginning to...

Read article ›

Pages